Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer


Acquired | Acquired

Total Raised




About Evotec Neurosciences

Evotec Neurosciences discovers and develops therapeutics for the treatment of Alzheimer's disease and other Central Nervous System (CNS) disorders with high unmet medical needs.On March 14, 2005, Evotec Neurosciences was acquired by Evotec at a valuation of $65.52M.

Evotec Neurosciences Headquarter Location

Schnackenburgallee 114

Hamburg, 22525,


49 40 560 81 0

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.